Search Share Prices
GSK Headlines - Goldman Sachs Group Analysts Give GlaxoSmithKline (GSK) a GBX 1,900 Price Target
Complete the form below to receive the latest headlines and analysts' recommendations for GlaxoSmithKline with our free daily email newsletter: Goldman Sachs Group set a GBX 1,900 ($24.83) target pric...
GlaxoSmithKline (GSK) Given Hold Rating at Liberum Capital
Complete the form below to receive the latest headlines and analysts' recommendations for GlaxoSmithKline with our free daily email newsletter: Liberum Capital reissued their hold rating on shares of ...
UK government to pump millions into antibiotics research for superbug fight
According to the Antimicrobial Resistance Benchmark (ARB), which was revealed on Wednesday at the World Economic Forum in Davos and aims to rank global pharma companies on their efforts to combat anti ...
Reckitt Benckiser plunges as US investment bank slams ‘weak’ work culture
The analysts argue that the merger of GlaxoSmithKline PLC’s (LON:GSK) and Pfizer’s consumer health businesses – Reckitt was interested in Pfizer’s assets – might have been “the straw that broke Kapoor ...
Should You Be Impressed By GlaxoSmithKline plc’s (LON:GSK) ROE?
One of the best investments we can make is in our own knowledge and skill set. With that in mind, this article will work through how we can use Return On Equity (ROE) to better understand a business.